524632 SHUKRAPHAR

Shukra Pharmaceuticals Share Price

 

 

Start SIP in SHUKRAPHAR

Start SIP

Performance

  • Low
  • ₹44
  • High
  • ₹47
  • 52 Week Low
  • ₹12
  • 52 Week High
  • ₹65
  • Open Price₹46
  • Previous Close₹45
  • Volume576,110
  • 50 DMA₹45.42
  • 100 DMA₹41.82
  • 200 DMA₹34.47

Investment Returns

  • Over 1 Month -1.21%
  • Over 3 Month + 14.06%
  • Over 6 Month + 149.49%
  • Over 1 Year + 112.8%

Smart Investing Starts Here Start SIP with Shukra Pharmaceuticals for Steady Growth!

Invest Now

Shukra Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 70.3
  • PEG Ratio
  • 0.3
  • Market Cap Cr
  • 2,049
  • P/B Ratio
  • 31.1
  • Average True Range
  • 2.85
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -2.56
  • RSI
  • 49.35
  • MFI
  • 65.17

Shukra Pharmaceuticals Financials

Shukra Pharmaceuticals Technicals

EMA & SMA

Current Price
₹46.79
+ 2.22 (4.98%)
pointer
  • Bearish Moving Average 2
  • Bullish Moving Average 14
  • 20 Day
  • ₹43.93
  • 50 Day
  • ₹45.42
  • 100 Day
  • ₹41.82
  • 200 Day
  • ₹34.47

Resistance and Support

44.57 Pivot Speed
  • R3 44.57
  • R2 44.57
  • R1 44.57
  • S1 44.57
  • S2 44.57
  • S3 44.57

Shukra Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-04 Quarterly Results (Revised) alia, 1. To consider in principle, the issue of equity shares of face value of Rs. 10/- each on a rights basis ("Rights Issue") to the shareholders of the Company.
2025-11-13 Quarterly Results
2025-10-03 Others Inter-alia, to consider 1. To declare and fix relevant date for the Pproposed preferential issue. 2. fix day, date, time and venue for Extra-ordinary General meeting (EGM). 3. Other business matters. alia, 1. To consider in principle, the issue of equity shares of face value of Rs. 10/- each on a rights basis ("Rights Issue") to the shareholders of the Company.
2025-08-13 Quarterly Results
2025-06-04 Final Dividend
Date Purpose Remarks
2025-09-18 FINAL Rs.0.01 per share(1%)Final Dividend
View Shukra Pharmaceuticals Dividend History Arrow
Date Purpose Remarks
2025-03-21 Split Rs.0.00 split from Rs. 10/- to Re. 1/-.
Date Purpose Remarks
2024-04-20 Bonus Rs.0.00 issue in the ratio of 3:1 of Rs. 10/-.

Shukra Pharmaceuticals F&O

Shukra Pharmaceuticals Shareholding Pattern

50.96%
0.11%
9.42%
39.51%

About Shukra Pharmaceuticals

  • NSE Symbol
  • SHUKRAPHAR
  • BSE Symbol
  • 524632
  • Managing Director
  • Mr. Dakshesh Rameshchandra Shah
  • ISIN
  • INE551C01044

Similar Stocks to Shukra Pharmaceuticals

Shukra Pharmaceuticals FAQs

Shukra Pharmaceuticals share price is ₹46 As on 10 February, 2026 | 10:58

The Market Cap of Shukra Pharmaceuticals is ₹2048.8 Cr As on 10 February, 2026 | 10:58

The P/E ratio of Shukra Pharmaceuticals is 70.3 As on 10 February, 2026 | 10:58

The PB ratio of Shukra Pharmaceuticals is 31.1 As on 10 February, 2026 | 10:58

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23